Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

The Availability Heuristic01:08

The Availability Heuristic

7.3K
A heuristic is a general problem-solving framework (Tversky & Kahneman, 1974). You can think of these as mental shortcuts that are used to solve problems. Different types of heuristics are used in different types of situations, and the impulse to use a heuristic occurs when one of five conditions is met (Pratkanis, 1989):
7.3K

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Therapeutic advances in Graves' orbitopathy: From corticosteroids to targeted immunotherapy - Insights from the TOGO and THRIVE trials.

Annales d'endocrinologie·2026
Same author

French expert consensus statement on diagnosis and management of primary hyperparathyroidism.

Annales d'endocrinologie·2025
Same author

Key data from the 2024 European Thyroid Association Congress. Graves' orbitopathy: Old recipes or new cuisine?

Annales d'endocrinologie·2025
Same author

Chapter 10: What parathyroid imaging is required for hyperparathyroidism?

Annales d'endocrinologie·2025
Same author

Chapter 15: Recurrent or persistent primary hyperparathyroidism, parathyromatosis.

Annales d'endocrinologie·2025
Same author

Key data from the 2023 European Thyroid Association congress: Breakthrough advances in the treatment of Graves' orbitopathy.

Annales d'endocrinologie·2024

Related Experiment Video

Updated: Mar 20, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K

[Not Available].

Miriam Ladsous1

  • 1CHRU, université de Lille 2, Clinique endocrinologique Marc-Linquette, 59037 Lille cedex, France.

Presse Medicale (Paris, France : 1983)
|June 1, 2016
PubMed
Summary
This summary is machine-generated.

Rituximab shows promise for Graves

More Related Videos

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.9K

Related Experiment Videos

Last Updated: Mar 20, 2026

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities
12:33

High-throughput Fluorometric Measurement of Potential Soil Extracellular Enzyme Activities

Published on: November 15, 2013

48.7K
Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles
14:02

Ex Vivo Assessment of Contractility, Fatigability and Alternans in Isolated Skeletal Muscles

Published on: November 1, 2012

25.1K
A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos
07:29

A Submerged Filter Paper Sandwich for Long-term Ex Ovo Time-lapse Imaging of Early Chick Embryos

Published on: December 28, 2016

22.9K

Area of Science:

  • Ophthalmology
  • Endocrinology
  • Immunology

Background:

  • Graves' orbitopathy (GO) is an autoimmune condition affecting the eye socket.
  • Current treatments for GO have limitations.
  • Rituximab, an anti-CD20 monoclonal antibody, is being explored for GO treatment.

Purpose of the Study:

  • To evaluate the efficacy and safety of rituximab in patients with Graves' orbitopathy.
  • To clarify the precise role of rituximab in the therapeutic management of GO.
  • To assess the safety profile of rituximab in a larger patient cohort.

Main Methods:

  • Systematic review of existing literature.
  • Meta-analysis of randomized controlled trials and observational studies.
  • Assessment of clinical outcomes and adverse events associated with rituximab therapy.

Main Results:

  • Rituximab demonstrates potential benefits in managing Graves' orbitopathy symptoms.
  • Further large-scale studies are required to confirm efficacy and long-term safety.
  • The optimal dosage and treatment protocols for rituximab in GO need further investigation.

Conclusions:

  • Rituximab presents a potential therapeutic option for Graves' orbitopathy.
  • Its definitive role and safety require validation through extensive clinical trials.
  • More research is needed to establish rituximab as a standard treatment for GO.